Related Experiment Video
Updated: Jul 16, 2026

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder
Eric A Storch1, Heather Lehmkuhl, Gary R Geffken
1Department of Psychiatry, University of Florida, Gainesville, Florida 32610, USA. estorch@psychiatry.ufl.edu
Abstract:
We report the case of adolescent male with obsessive-compulsive disorder (OCD) who had an incomplete response to combined cognitive-behavioral therapy (CBT) and sertraline before successful augmentation of CBT with aripiprazole. Standardized assessments indicated significant reductions in OCD symptomatology associated with both initial treatment and aripiprazole augmentation. This case suggests that aripiprazole may have utility as an augmenting agent of CBT in adolescents with OCD and underscores the need for conducting controlled studies to test this hypothesis.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Antipsychotic Drugs: Typical and Atypical Agents
Obsessive-Compulsive Disorder
Drug Therapy
Antianxiety Medications
Antidepressant Drugs: MAOIs and Other Agents